Rotonya M. Carr
#175,989
Most Influential Person Now
American hepatologist and physician-scientist
Rotonya M. Carr's AcademicInfluence.com Rankings
Rotonya M. Carrphilosophy Degrees
Philosophy
#12483
World Rank
#17338
Historical Rank
#2450
USA Rank
Logic
#9329
World Rank
#11812
Historical Rank
#1643
USA Rank
Download Badge
Philosophy
Rotonya M. Carr's Degrees
- PhD Biomedical Sciences Mayo Clinic Graduate School of Biomedical Sciences
Why Is Rotonya M. Carr Influential?
(Suggest an Edit or Addition)According to Wikipedia, Rotonya McCants Carr is an American hepatologist and physician-scientist who the function of lipid metabolites and lipid droplet proteins in relation to hepatic insulin signaling. She is the Cyrus E. Rubin Chair and division head of gastroenterology at the University of Washington.
Rotonya M. Carr's Published Works
Published Works
- Nonalcoholic Fatty Liver Disease: Pathophysiology and Management. (2016) (169)
- Predictors of Outcomes of COVID-19 in Patients With Chronic Liver Disease: US Multi-center Study (2020) (148)
- Pathophysiology of lipid droplet proteins in liver diseases. (2016) (115)
- FXR Agonists as Therapeutic Agents for Non-alcoholic Fatty Liver Disease (2015) (86)
- Absence of Perilipin 2 Prevents Hepatic Steatosis, Glucose Intolerance and Ceramide Accumulation in Alcohol-Fed Mice (2014) (85)
- Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based Study. (2017) (72)
- FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid. (2018) (70)
- Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice. (2012) (67)
- Alcohol effects on hepatic lipid metabolism (2020) (63)
- A new perspective on NAFLD: focusing on lipid droplets. (2021) (56)
- Liver Injury in Liver Transplant Recipients With Coronavirus Disease 2019 (COVID‐19): U.S. Multicenter Experience (2020) (55)
- Outcome of COVID‐19 in Patients With Autoimmune Hepatitis: An International Multicenter Study (2021) (52)
- Academic careers and the COVID-19 pandemic: Reversing the tide (2021) (52)
- Temporal effects of ethanol consumption on energy homeostasis, hepatic steatosis, and insulin sensitivity in mice. (2013) (49)
- Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis (2018) (44)
- Insulin resistance in clinical and experimental alcoholic liver disease (2015) (38)
- Ethnic Disparities in Adiposity: Focus on Non-alcoholic Fatty Liver Disease, Visceral, and Generalized Obesity (2019) (32)
- Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients (2017) (27)
- Diversity Within US Gastroenterology Physician Practices: The Pipeline, Cultural Competencies, and Gastroenterology Societies Approaches. (2019) (27)
- Lipid Droplet Accumulation in Human Pancreatic Islets Is Dependent On Both Donor Age and Health (2019) (26)
- Genetic analysis in European ancestry individuals identifies 517 loci associated with liver enzymes (2021) (25)
- A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation (2021) (25)
- Reducing colorectal cancer risk among African Americans. (2015) (22)
- A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis (2018) (21)
- Effects of immunosuppressive drugs on COVID‐19 severity in patients with autoimmune hepatitis (2021) (19)
- From Intention to Action: Operationalizing AGA Diversity Policy to Combat Racism and Health Disparities in Gastroenterology (2020) (18)
- Perilipin Staining Distinguishes Between Steatosis and Nonalcoholic Steatohepatitis in Adults and Children (2017) (15)
- Liver-specific ceramide reduction alleviates steatosis and insulin resistance in alcohol-fed mice[S] (2020) (13)
- Acute granulocytic leukemia in Hodgkin's disease. (1975) (13)
- Associations of Liver Disease with Alcohol Use among People Living with HIV and the Role of Hepatitis C: The New Orleans Alcohol Use in HIV Study. (2019) (12)
- A genome-wide association study for nonalcoholic fatty liver disease identifies novel genetic loci and trait-relevant candidate genes in the Million Veteran Program. (2021) (11)
- Ethanol and C2 ceramide activate fatty acid oxidation in human hepatoma cells (2018) (10)
- A genome-first approach to mortality and metabolic phenotypes in MTARC1 p.Ala165Thr (rs2642438) heterozygotes and homozygotes. (2021) (10)
- Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program (2020) (9)
- Socioeconomic Factors Contribute to the Higher Risk of COVID-19 in Racial and Ethnic Minorities With Chronic Liver Diseases (2020) (9)
- Experimental models of metabolic and alcoholic fatty liver disease (2021) (8)
- Summary of the 2019 Alcohol and Immunology Research Interest Group (AIRIG) meeting: Alcohol-mediated mechanisms of multiple organ injury. (2020) (7)
- Non-alcoholic fatty liver disease: Pathophysiology and management (2016) (6)
- Alas! Ileal interposition surgery for diabetes prevention? (2010) (6)
- Reflections of a Black woman physician-scientist. (2020) (6)
- A Phenome-Wide Association Study of genes associated with COVID-19 severity reveals shared genetics with complex diseases in the Million Veteran Program (2021) (6)
- Quantification of abdominal fat from computed tomography using deep learning and its association with electronic health records in an academic biobank (2020) (6)
- VCAM-1: closing the gap between lipotoxicity and endothelial dysfunction in nonalcoholic steatohepatitis. (2021) (5)
- A Phenome-Wide Association Study of genes associated with COVID-19 severity reveals shared genetics with complex diseases in the Million Veteran Program (2022) (5)
- At the crossroads in the management of gastroesophageal junction carcinomas-where do we go from here? (2008) (4)
- High-Risk Groups for Non-alcoholic Fatty Liver and Non-alcoholic Steatohepatitis Development and Progression (2020) (4)
- Advancing health equity: The Association of Black Gastroenterologists and Hepatologists (2021) (3)
- Linking abdominal imaging traits to electronic health record phenotypes (2020) (2)
- The Impact of Peri-discharge Interventions on 30-Day Readmission and 90-Day Mortality Rates for Patients Admitted With Hepatic Encephalopathy: 439 (2014) (2)
- Rapid Lipid Droplet Isolation Protocol Using a Well-established Organelle Isolation Kit. (2019) (2)
- Tu2007 Headache With Hematochezia: A Case of Sumatriptan-Induced Ischemic Colitis (2013) (1)
- PPPIs, Enterococcus and the Liver, Oh My! (2018) (1)
- In NAFLD, You Are What You Eat, Not Simply How Much You Eat (2017) (1)
- Transition of Care Model for Pediatric Patients With Nonalcoholic Fatty Liver Disease (2021) (1)
- 1261 REDUCTION OF TIP47 IMPROVES HEPATIC STEATOSIS AND GLUCOSE HOMEOSTASIS IN DIET-INDUCED OBESE MICE (2011) (1)
- Proton pump inhibitors, Enterococcus, and the liver, oh my! (2018) (1)
- Understanding the Pathogenesis of Insulin Resistance in Non-Alcoholic and Alcoholic Liver Diseases (2014) (0)
- 124 The risk of liver disease in psoriasis patients: A population-based cohort (2016) (0)
- Update on Cause and Management of Catscratch Disease (2008) (0)
- Triples Championship 2011 Venue Halekulani (2011) (0)
- Ethanol and C2 ceramide activate fatty acid oxidation in human hepatoma cells (2018) (0)
- Mo1261 Metabolic Syndrome and IBD Severity May Increase Risk of NAFLD (2013) (0)
- Concomitant western diet and chronic-binge alcohol dysregulate hepatic metabolism (2023) (0)
- DDS Profile: Rotonya M. Carr, MD, FACP (2022) (0)
- α-Galactosylceramide: a potent immunomodulator produced by gut microbes1 (2019) (0)
- Abstract 5061: ALDH2 restricts esophageal stem/progenitor cell expansion via autophagy under alcohol-induced mitochondrial stress (2018) (0)
- Faculty Opinions recommendation of Early liver transplantation for severe alcoholic hepatitis. (2011) (0)
- Mo1737 – Aldh2 and Autophaghy-Mediated Redox Homeostasis Limit the Alcohol-Induced Expansion of Esophageal Cancer Stem Cells (2019) (0)
- Presentation of the Julius M. Friedenwald Medal to Anil K. Rustgi. (2017) (0)
- Building bridges: PCSK7 as a NAFLD candidate gene connecting hepatic inflammation with hypertriglyceridemia1 (2019) (0)
- Long-term clinical outcomes of patients with COVID-19 and chronic liver disease: US multicenter COLD study (2023) (0)
- Rapid Identification and Phenotyping of Nonalcoholic Fatty Liver Disease Patients Using an Automated Algorithmic Approach in Diverse, Urban Healthcare Systems (2021) (0)
- 319 – Hepatic Ceramide Reduction Alleviates Alcoholic Steatosis and Insulin Resistance in Female Mice (2019) (0)
- Nature or Nurture? The Answer Is “Both” in Nonalcoholic Steatohepatitis (2020) (0)
- AMERICAN GASTROENTEROLOGICAL ASSOCIATION (AGA) MEMBERSHIP POLICY PRORITIES - BUILDING THE AGA ADVOCACY AGENDA. (2023) (0)
- Tu1300: PERILIPIN2 S251 POLYMORPHISM PROTECTS FROM LIVER TRIGLYCERIDE ACCUMULAITON. (2022) (0)
- PATTERNS AND PREDICTORS OF LIVER INJURY IN LIVER TRANSPLANT RECIPIENTS WITH CORONAVIRUS DISEASE 2019 (COVID-19) (2020) (0)
- Ceramide synthase 6 (CerS6) promotes alcohol-induced fatty liver by promoting metabolic dysfunction and upregulating lipid droplet-associated proteins (2022) (0)
- DDS Perspective: Time to Get Serious About the Global Pandemic (2022) (0)
This paper list is powered by the following services:
Other Resources About Rotonya M. Carr
What Schools Are Affiliated With Rotonya M. Carr?
Rotonya M. Carr is affiliated with the following schools: